{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:07:31Z","timestamp":1745467651655,"version":"3.40.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-025-03710-y","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:18:36Z","timestamp":1745389116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarker-guided strategy for Denver peritoneovenous shunts in refractory ascites: a retrospective single-center study"],"prefix":"10.1007","volume":"410","author":[{"given":"Yuhi","family":"Shimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-2473","authenticated-orcid":false,"given":"Shohei","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"3710_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1089\/jpm.2012.0535","volume":"16","author":"NA Coupe","year":"2013","unstructured":"Coupe NA, Cox K, Clark K, Boyer M, Stockler M (2013) Outcomes of permanent peritoneal. Ports for the management of recurrent malignant Ascites. J Palliat Med 16:938\u2013940. https:\/\/doi.org\/10.1089\/jpm.2012.0535","journal-title":"J Palliat Med"},{"key":"3710_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jvir.2013.05.042","volume":"24","author":"MP Lungren","year":"2013","unstructured":"Lungren MP, Kim CY, Stewart JK, Smith TP, Miller MJ (2013) Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol 24:1303\u20131308. https:\/\/doi.org\/10.1016\/j.jvir.2013.05.042","journal-title":"J Vasc Interv Radiol"},{"key":"3710_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/clon.2002.0135","volume":"15","author":"EM Smith","year":"2003","unstructured":"Smith EM, Jayson GC (2003) The current and future management of malignant Ascites. Clin Oncol (R Coll Radiol) 15:59\u201372. https:\/\/doi.org\/10.1053\/clon.2002.0135","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"3710_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0889-8553(21)00616-6","volume":"21","author":"V Arroyo","year":"1992","unstructured":"Arroyo V, Gin\u00e8s P, Planas R (1992) Treatment of Ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis. Gastroenterol Clin North Am 21:237\u2013256","journal-title":"Gastroenterol Clin North Am"},{"key":"3710_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/01.rvi.0000136828.42612.b4","volume":"15","author":"S Rosenberg","year":"2004","unstructured":"Rosenberg S, Courtney A, Nemcek AA Jr, Omary RA (2004) Comparison of percutaneous management techniques for recurrent malignant Ascites. J Vasc Interv Radiol 15:1129\u20131131. https:\/\/doi.org\/10.1097\/01.rvi.0000136828.42612.b4","journal-title":"J Vasc Interv Radiol"},{"key":"3710_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-021-02077-6","volume":"27","author":"K Matsusaki","year":"2022","unstructured":"Matsusaki K, Aridome K, Emoto S, Kajiyama H, Takagaki N, Takahashi T, Tsubamoto H, Nagao S, Watanabe A, Shimada H, Kitayama J (2022) Clinical practice guideline for the treatment of malignant ascites: section summary in clinical practice guideline for peritoneal dissemination (2021). Int J Clin Oncol 27:1\u20136. https:\/\/doi.org\/10.1007\/s10147-021-02077-6","journal-title":"Int J Clin Oncol"},{"key":"3710_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jvir.2022.12.037","volume":"34","author":"BM Currie","year":"2023","unstructured":"Currie BM, Bakhtiar M, Nadolski GJ, Soulen MC (2023) Mitigation of sarcopenia after peritoneovenous shunt placement in patients with refractory Ascites. J Vasc Interv Radiol 34:633\u2013638. https:\/\/doi.org\/10.1016\/j.jvir.2022.12.037","journal-title":"J Vasc Interv Radiol"},{"key":"3710_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/fon.09.136","volume":"6","author":"CS Roxburgh","year":"2010","unstructured":"Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149\u2013163. https:\/\/doi.org\/10.2217\/fon.09.136","journal-title":"Future Oncol"},{"key":"3710_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.20524\/aog.2020.0534","volume":"33","author":"T Oikonomou","year":"2020","unstructured":"Oikonomou T, Goulis I, Kiapidou S, Tagkou N, Akriviadis E, Papatheodoridis G, Cholongitas E (2020) The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis. Ann Gastroenterol 33:667\u2013674. https:\/\/doi.org\/10.20524\/aog.2020.0534","journal-title":"Ann Gastroenterol"},{"key":"3710_CR10","doi-asserted-by":"publisher","first-page":"e3781","DOI":"10.1097\/md.0000000000003781","volume":"95","author":"M Kanda","year":"2016","unstructured":"Kanda M, Mizuno A, Tanaka C, Kobayashi D, Fujiwara M, Iwata N, Hayashi M, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Takami H, Niwa Y, Murotani K, Kodera Y (2016) Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Med (Baltim) 95:e3781. https:\/\/doi.org\/10.1097\/md.0000000000003781","journal-title":"Med (Baltim)"},{"key":"3710_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12957-016-1044-9","volume":"14","author":"Y Wu","year":"2016","unstructured":"Wu Y, Li C, Zhao J, Yang L, Liu F, Zheng H, Wang Z, Xu Y (2016) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol 14:289. https:\/\/doi.org\/10.1186\/s12957-016-1044-9","journal-title":"World J Surg Oncol"},{"key":"3710_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/s0002-9610(06)80078-4","volume":"159","author":"DW Weaver","year":"1990","unstructured":"Weaver DW, Wiencek RG, Bouwman DL (1990) Percutaneous Denver peritoneovenous shunt insertion. Am J Surg 159:600\u2013601. https:\/\/doi.org\/10.1016\/s0002-9610(06)80078-4","journal-title":"Am J Surg"},{"key":"3710_CR13","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1002\/1097-0142(20010401)91","volume":"16","author":"H Tamagawa","year":"2020","unstructured":"Tamagawa H, Aoyama T, Inoue H, Fujikawa H, Sawazaki S, Numata M, Sato T, Oshima T, Yukawa N, Morimoto M, Ueno M, Rino Y, Masuda M (2020) Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant Ascites. J Cancer Res Ther 16:S95\u2013S98. https:\/\/doi.org\/10.1002\/1097-0142(20010401)91:7%3C1247::AID-CNCR1125%3E3.0.CO;2-W","journal-title":"J Cancer Res Ther"},{"key":"3710_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00270-004-0146-x","volume":"27","author":"FF Hussain","year":"2004","unstructured":"Hussain FF, Meer ZF, Lopez AJ (2004) Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience. Cardiovasc Intervent Radiol 27:325\u2013328. https:\/\/doi.org\/10.1007\/s00270-004-0146-x","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3710_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/s1051-0443(07)61707-2","volume":"12","author":"JS Park","year":"2001","unstructured":"Park JS, Won JY, Park SI, Park SJ, Lee DY (2001) Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory Ascites. J Vasc Interv Radiol 12:1445\u20131448. https:\/\/doi.org\/10.1016\/s1051-0443(07)61707-2","journal-title":"J Vasc Interv Radiol"},{"key":"3710_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00270-010-0057-y","volume":"34","author":"S Sugawara","year":"2011","unstructured":"Sugawara S, Sone M, Arai Y, Sakamoto N, Aramaki T, Sato Y, Inaba Y, Takeuchi Y, Ueno T, Matsueda K, Moriguchi M, Tsushima T (2011) Radiological insertion of Denver peritoneovenous shunts for malignant refractory ascites: a retrospective multicenter study (JIVROSG-0809). Cardiovasc Intervent Radiol 34:980\u2013988. https:\/\/doi.org\/10.1007\/s00270-010-0057-y","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3710_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.dld.2021.12.007","volume":"54","author":"V Will","year":"2022","unstructured":"Will V, Rodrigues SG, Berzigotti A (2022) Current treatment options of refractory Ascites in liver cirrhosis - A systematic review and meta-analysis. Dig Liver Dis 54:1007\u20131014. https:\/\/doi.org\/10.1016\/j.dld.2021.12.007","journal-title":"Dig Liver Dis"},{"issue":"20010401","key":"3710_CR18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/1097-0142","volume":"91","author":"SC Bieligk","year":"2001","unstructured":"Bieligk SC, Calvo BF, Coit DG (2001) Peritoneovenous shunting for nongynecologic malignant Ascites. Cancer 91(20010401):1247\u20131255. https:\/\/doi.org\/10.1002\/1097-014291:73C1247::aid-cncr11253E3.0.co;2-w.","journal-title":"Cancer"},{"key":"3710_CR19","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.3390\/nu15194179","volume":"15","author":"A Mizerska","year":"2023","unstructured":"Mizerska A, Durlik M, K\u0119dzierska-Kapuza K (2023) Nutritional risk of candidates for simultaneous pancreatic-kidney transplantation-a narrative review. Nutrients 15:4179. https:\/\/doi.org\/10.3390\/nu15194179","journal-title":"Nutrients"},{"key":"3710_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijsu.2018.05.030","volume":"55","author":"D Tan","year":"2018","unstructured":"Tan D, Fu Y, Tong W, Li F (2018) Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis. Int J Surg 55:128\u2013138. https:\/\/doi.org\/10.1016\/j.ijsu.2018.05.030","journal-title":"Int J Surg"},{"key":"3710_CR21","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.2147\/jir.s437256","volume":"16","author":"Y Yu","year":"2023","unstructured":"Yu Y, Zhong Z, Yang W, Yu J, Li J, Guo X, Chen J, Mao H, Li Z (2023) Neutrophil percentage-to-albumin ratio and risk of mortality in patients on peritoneal dialysis. J Inflamm Res 16:6271\u20136281. https:\/\/doi.org\/10.2147\/jir.s437256","journal-title":"J Inflamm Res"},{"key":"3710_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2017.05.005","volume":"58","author":"Z Mei","year":"2017","unstructured":"Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P, Wang Q, Yang W (2017) Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies. Cancer Treat Rev 58:1\u201313. https:\/\/doi.org\/10.1016\/j.ctrv.2017.05.005","journal-title":"Cancer Treat Rev"},{"key":"3710_CR23","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.cgh.2018.04.045","volume":"16","author":"J Rice","year":"2018","unstructured":"Rice J, Dodge JL, Bambha KM, Bajaj JS, Reddy KR, Gralla J, Ganapathy D, Mitrani R, Reuter B, Palecki J, Acharya C, Shaw J, Burton JR, Biggins SW (2018) Neutrophil-to-lymphocyte ratio associates independently with mortality in hospitalized patients with cirrhosis. Clin Gastroenterol Hepatol 16:1786\u20131791e1. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.045","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3710_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5414\/cn108584","volume":"85","author":"E Ahbap","year":"2016","unstructured":"Ahbap E, Sakaci T, Kara E, Sahutoglu T, Koc Y, Basturk T, Sevinc M, Akgol C, Kayalar AO, Ucar ZA, Bayraktar F, Unsal A (2016) Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol 85:199\u2013208. https:\/\/doi.org\/10.5414\/cn108584","journal-title":"Clin Nephrol"},{"key":"3710_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/0886022x.2011.641514","volume":"34","author":"K Turkmen","year":"2012","unstructured":"Turkmen K, Guney I, Yerlikaya FH, Tonbul HZ (2012) The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail 34:155\u2013159. https:\/\/doi.org\/10.3109\/0886022x.2011.641514","journal-title":"Ren Fail"},{"key":"3710_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/0886022X.2018.1455590","volume":"40","author":"S Tonyali","year":"2018","unstructured":"Tonyali S, Ceylan C, Yahsi S, Karakan MS (2018) Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function? Ren Fail 40:209\u2013212. https:\/\/doi.org\/10.1080\/0886022X.2018.1455590","journal-title":"Ren Fail"},{"key":"3710_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jvir.2015.12.014","volume":"27","author":"H Yarmohammadi","year":"2016","unstructured":"Yarmohammadi H, Brody LA, Erinjeri JP, Covey AM, Boas FE, Ziv E, Maybody M, Gonzalez-Aguirre AJ, Brown KT, Sheinfeld J, Getrajdman GI (2016) Therapeutic application of percutaneous peritoneovenous (Denver) shunt in treating chylous Ascites in cancer patients. J Vasc Interv Radiol 27:665\u2013673. https:\/\/doi.org\/10.1016\/j.jvir.2015.12.014","journal-title":"J Vasc Interv Radiol"},{"key":"3710_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ajpath.2016.01.008","volume":"186","author":"S Gupta","year":"2016","unstructured":"Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE (2016) Transforming growth factor-\u03b2 is an upstream regulator of mammalian target of Rapamycin complex 2-dependent bladder cancer cell migration and invasion. Am J Pathol 186:1351\u20131360. https:\/\/doi.org\/10.1016\/j.ajpath.2016.01.008","journal-title":"Am J Pathol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-025-03710-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:18:36Z","timestamp":1745389116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-025-03710-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1007\/s00423-025-03710-y","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the standards of the Declaration of Helsinki and was approved by the Institutional Ethics Board of the Sumoto Itsuki Hospital in 2024 (approval number # 24\u20130201). Reporting of this study adhered to the STROBE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}